<DOC>
	<DOCNO>NCT00723307</DOCNO>
	<brief_summary>Hypothesis : Treatment metformin overweight non-diabetic individual coronary heart disease standard cardiovascular risk reduce agent include statin beneficial impact carotid artery atherosclerosis compare placebo . Rationale : Once subject heart attack , remain much high average risk another heart attack stroke , despite best current therapy lower cholesterol blood pressure thin blood . Many subject heart disease also problem metabolise ( i.e . processing ) sugar even diabetes . There evidence metformin , drug improves sugar metabolism , decrease risk future heart attack diabetic patient . However , whether metformin reduces risk heart disease beyond establish treatment people without diabetes unknown . Method : The investigator test ability metformin , drug proven safety , slow progression furring ( know atherosclerosis ) blood vessel non-diabetic subject heart disease . This achieve treat 2 group subject metformin placebo pill respectively . To measure atherosclerosis , investigator carry ultrasound scan big blood vessel neck start study , 1 year 1.5 year therapy.The investigator able assess whether metformin beneficial impact .</brief_summary>
	<brief_title>Carotid Atherosclerosis : MEtformin Insulin ResistAnce Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Proven coronary heart disease ( prior acute coronary syndrome , prior CABG angiographically proven CHD ) Aged 3575 year Elevated waist circumference per International Diabetes Foundation criterion ( 94 cm men 80 cm woman ) All patient statin Pregnancy and/or lactation screen Premenopausal woman contraception Known newly diagnose diabetes mellitus oral glucose tolerance testing ( OGTT perform subject HbA1C 6.06.9 % fast plasma glucose [ FPG ] &lt; 7.0 mmol/L screening18 ) Screening result : HbA1C ≥ 7.0 % and/or fast plasma glucose ≥ 7.0 mmol/L Patients Acute Coronary Syndrome within last 3 month Clinically unstable heart failure Uncontrolled angina Contraindications metformin</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>No diabetes mellitus</keyword>
	<keyword>Elevated waist circumference</keyword>
</DOC>